<VariationArchive VariationID="265094" VariationName="NM_000781.3(CYP11A1):c.835del (p.Ile279fs)" VariationType="Deletion" Accession="VCV000265094" Version="4" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-06-17" DateCreated="2015-07-25" MostRecentSubmission="2023-11-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="260079" VariationID="265094">
      <GeneList>
        <Gene Symbol="CYP11A1" FullName="cytochrome P450 family 11 subfamily A member 1" GeneID="1583" HGNC_ID="HGNC:2590" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q24.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="74337762" stop="74367646" display_start="74337762" display_stop="74367646" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NW_021160016.1" start="167031" stop="196915" display_start="167031" display_stop="196915" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="74630102" stop="74660080" display_start="74630102" display_stop="74660080" Strand="-" />
          </Location>
          <OMIM>118485</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000781.3(CYP11A1):c.835del (p.Ile279fs)</Name>
      <CanonicalSPDI>NC_000015.10:74343131:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q24.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="74343132" stop="74343132" display_start="74343132" display_stop="74343132" variantLength="1" positionVCF="74343131" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="74635473" stop="74635473" display_start="74635473" display_stop="74635473" variantLength="1" positionVCF="74635472" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>I121fs</ProteinChange>
      <ProteinChange>I279fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.74343132del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.74343132del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.74635473del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.74635473del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007973.1" sequenceAccession="NG_007973" sequenceVersion="1" change="g.29610del">
            <Expression>NG_007973.1:g.29610del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000781.3" sequenceAccession="NM_000781" sequenceVersion="3" change="c.835del" MANESelect="true">
            <Expression>NM_000781.3:c.835del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000772.2" sequenceAccession="NP_000772" sequenceVersion="2" change="p.Ile279fs">
            <Expression>NP_000772.2:p.Ile279fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099773.2" sequenceAccession="NM_001099773" sequenceVersion="2" change="c.361del">
            <Expression>NM_001099773.2:c.361del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001093243.1" sequenceAccession="NP_001093243" sequenceVersion="1" change="p.Ile121fs">
            <Expression>NP_001093243.1:p.Ile121fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA7656448" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="118485.0004" DB="OMIM" />
        <XRef Type="rs" ID="757299093" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00003" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00005" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00007" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00008" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000781.3(CYP11A1):c.835del (p.Ile279fs) AND Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency" Accession="RCV000019071" Version="29">
        <ClassifiedConditionList TraitSetID="6746">
          <ClassifiedCondition DB="MedGen" ID="C3151055">Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-09-07" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000781.3(CYP11A1):c.835del (p.Ile279fs) AND not provided" Accession="RCV000255976" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-03-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000781.3(CYP11A1):c.835del (p.Ile279fs) AND CYP11A1-related disorder" Accession="RCV003409385" Version="4">
        <ClassifiedConditionList TraitSetID="91728">
          <ClassifiedCondition>CYP11A1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-28" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2015-07-25" MostRecentSubmission="2023-11-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15507506</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18182448</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21159840</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6746" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15740" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Congenital adrenal insuffiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency</ElementValue>
                <XRef ID="MONDO:0013400" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete</ElementValue>
                <XRef ID="Adrenal+insufficiency%2C+congenital%2C+with+46%2CXY+sex+reversal%2C+partial+or+complete/7637" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">P450scc DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="613743" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17033" />
                <XRef ID="17033" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">P450scc deficiency is a rare disorder that can present as acute adrenal insufficiency in infancy or childhood. ACTH and plasma renin activity are grossly elevated and adrenal steroids are inappropriately low or absent; the 46,XY patients have female external genitalia, sometimes with clitoromegaly. The phenotypic spectrum ranges from prematurity, complete underandrogenization, and severe early-onset adrenal failure to term birth with clitoromegaly and later-onset adrenal failure (summary by Kim et al., 2008).
Although hormonal and phenotypic features can resemble those of congenital lipoid adrenal hyperplasia (lipoid CAH; 201710), no patient with P450scc deficiency has been described with the massive adrenal enlargement typical of lipoid CAH (summary by Sahakitrungruang et al., 2011).</Attribute>
                <XRef Type="MIM" ID="613743" DB="OMIM" />
              </AttributeSet>
              <XRef ID="168558" DB="Orphanet" />
              <XRef ID="C3151055" DB="MedGen" />
              <XRef ID="MONDO:0013400" DB="MONDO" />
              <XRef Type="MIM" ID="613743" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="91728" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="69709" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">CYP11A1-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CYP11A1-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="39358" SubmissionDate="2015-07-22" DateLastUpdated="2015-07-25" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="118485.0004_ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE" title="CYP11A1, 1-BP DEL, 835A _ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE" />
        <ClinVarAccession Accession="SCV000039358" DateUpdated="2015-07-25" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Hiort et al. (2005) reported a 46,XY patient with a homozygous defect of CYP11A1. This child was born prematurely with sex reversal and severe adrenal insufficiency (613743). Laboratory data showed diminished or absent steroidogenesis in all pathways. Molecular genetic analysis of the CYP11A1 gene revealed a homozygous single-nucleotide deletion of adenine at position 835 in exon 5, leading to a premature termination at codon 288. This mutation was predicted to delete highly conserved regions of the P450scc enzyme and thus to lead to a nonfunctional protein. Both healthy parents were heterozygous for this mutation. Hiort et al. (2005) stated that this was the first report of an inherited disruptive mutation in the CYP11A1 gene.</Attribute>
              <Citation>
                <ID Source="PubMed">15507506</ID>
              </Citation>
              <XRef DB="OMIM" ID="613743" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Kim et al. (2008) described a patient with 46,XY sex reversal and primary adrenal failure who was compound heterozygous for the 835delA mutation and a splice site mutation (IVS3+(2-3)insT; 118485.0006). External genitalia were those of a normal female; no gonads, internal reproductive structures, or adrenals were identified by MRI or ultrasound, and a genitogram revealed a blind vaginal pouch. Functional studies in COS-1 cells demonstrated no activity of 835delA-mutated P450scc. The IVS3+(2-3)insT mutation introduces an additional thymidine after the second base of the third intron that was predicted to disrupt the splice donor site. PCR amplification of RNA demonstrated that sequences corresponding to intron 3 had been retained, resulting in a nonfunctional protein.</Attribute>
              <Citation>
                <ID Source="PubMed">18182448</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Sahakitrungruang et al. (2010) identified the 835delA mutation in 2 sibs with adrenal insufficiency. The 46,XY sib had micropenis, severe hypospadias, bifid scrotum, and cryptorchidism; the other sib was 46,XX with normal female genitalia. The sibs carried the 835delA mutation in compound heterozygosity with a missense mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">21159840</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP11A1" />
          </GeneList>
          <Name>CYP11A1, 1-BP DEL, 835A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 835A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="118485.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="616191" SubmissionDate="2019-01-29" DateLastUpdated="2016-10-10" DateCreated="2016-10-10">
        <ClinVarSubmissionID localKey="GDX:16738|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000321537" DateUpdated="2016-10-10" DateCreated="2016-10-10" Type="SCV" Version="6" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-03-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.835delA pathogenic variant in the CYP11A1 gene has been reported in the homozygous state in an individual with severe adrenal failure and complete 46,XY sex reversal (Hiort et al., 2005). The c.835delA variant was not observed with any significant frequency in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The c.835delA variant causes a frameshift starting with codon Isoleucine 279, changes this amino acid to a Tyrosine residue and creates a premature Stop codon at position 10 of the new reading frame, denoted p.Ile279TyrfsX10. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Functional studies show that the c.835delA variant lacks detectable enzymatic activity (Tee et al., 2013). We interpret c.835delA as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP11A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000781.2:c.835delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5464389" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000781.3:c.835del|OMIM:613743" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002808308" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000781.3:c.835del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613743" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7697283" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="15422479|CYP11A1-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004113350" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The CYP11A1 c.835delA variant is predicted to result in a frameshift and premature protein termination (p.Ile279Tyrfs*10). This variant has been reported to be pathogenic for XY sex reversal and adrenal insufficiency (see for example at Hiort et al. 2005. PubMed ID: 15507506; Tee et al. 2013. PubMed ID: 23337730). This variant is reported in 0.0062% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/15-74635472-AT-A). Frameshift variants in CYP11A1 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP11A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000781.2:c.835delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CYP11A1-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="39358" TraitType="Disease" MappingType="Name" MappingValue="ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE" MappingRef="Preferred">
        <MedGen CUI="C3151055" Name="Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="616191" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7697283" TraitType="Disease" MappingType="Name" MappingValue="CYP11A1-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="CYP11A1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5464389" TraitType="Disease" MappingType="XRef" MappingValue="613743" MappingRef="OMIM">
        <MedGen CUI="C3151055" Name="Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

